IS1822B - Glýkósamstæður, lyf sem innihalda þær, og notkun glýkósamstæðnanna við framleiðslu lyfja - Google Patents

Glýkósamstæður, lyf sem innihalda þær, og notkun glýkósamstæðnanna við framleiðslu lyfja

Info

Publication number: IS1822B
Authority: IS; Iceland
Prior art keywords: glycosides; drugs; manufacture; drugs containing; cytostatics
Prior art date: 1995-04-04

Application number

IS4562A

Other languages

English (en)

Other versions

IS4562A (is

Inventor

Lerchen Hans-Georg

Von Dem Bruch Karsten

Petersen Uwe

Baumgarten Jörg

Piel Norbert

Antonicek Horst-Peter

Weichel Walter

Sperzel Michael

Dieter Bremm Klaus

Original Assignee

Bayer Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-04

Filing date

1997-09-18

Publication date

2002-10-01

1997-09-18 Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft

1997-09-18 Publication of IS4562A publication Critical patent/IS4562A/is

2002-10-01 Publication of IS1822B publication Critical patent/IS1822B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicinal Preparation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Pyrane Compounds (AREA)
Steroid Compounds (AREA)
Peptides Or Proteins (AREA)

IS4562A 1995-04-04 1997-09-18 Glýkósamstæður, lyf sem innihalda þær, og notkun glýkósamstæðnanna við framleiðslu lyfja IS1822B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19512484A DE19512484A1 (de)	1995-04-04	1995-04-04	Kohlenhydratmodifizierte Cytostatika
PCT/EP1996/001279 WO1996031532A1 (de)	1995-04-04	1996-03-22	Kohlenhydratmodifizierte cytostatika

Publications (2)

Publication Number	Publication Date
IS4562A IS4562A (is)	1997-09-18
IS1822B true IS1822B (is)	2002-10-01

Family

ID=7758679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4562A IS1822B (is)	1995-04-04	1997-09-18	Glýkósamstæður, lyf sem innihalda þær, og notkun glýkósamstæðnanna við framleiðslu lyfja

Country Status (27)

Country	Link
US (1)	US6271342B1 (is)
EP (1)	EP0819135B1 (is)
JP (1)	JPH11502860A (is)
KR (1)	KR19980703591A (is)
CN (1)	CN1185786A (is)
AT (1)	ATE186738T1 (is)
AU (1)	AU713466B2 (is)
BG (1)	BG63048B1 (is)
BR (1)	BR9604825A (is)
CA (1)	CA2217164A1 (is)
CZ (1)	CZ291098B6 (is)
DE (2)	DE19512484A1 (is)
DK (1)	DK0819135T3 (is)
EE (1)	EE03619B1 (is)
ES (1)	ES2140078T3 (is)
GR (1)	GR3032605T3 (is)
HU (1)	HUP9800513A3 (is)
IS (1)	IS1822B (is)
MX (1)	MX9707613A (is)
NO (1)	NO974564L (is)
NZ (1)	NZ305855A (is)
PL (1)	PL183574B1 (is)
RU (1)	RU2170234C2 (is)
SK (1)	SK281785B6 (is)
TW (1)	TW384290B (is)
UA (1)	UA61054C2 (is)
WO (1)	WO1996031532A1 (is)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2267328A1 (en) *	1996-09-30	1998-04-09	Bayer Aktiengesellschaft	Glycoconjugates from modified camptothecin derivates (20-o-linkage)
DE19640970A1 (de) *	1996-10-04	1998-04-16	Bayer Ag	Modifizierte Cytostatika
JP3101710B2 (ja)	1997-02-28	2000-10-23	工業技術院長	硫酸化オリゴ糖化合物
ID23424A (id) *	1997-05-14	2000-04-20	Bayer Ag	Glikokonjugat dari 20(s)-kamptotesin
US6387928B1 (en)	1997-09-15	2002-05-14	The Procter & Gamble Co.	Antimicrobial quinolones, their compositions and uses
AU735186B2 (en)	1997-09-15	2001-07-05	Warner Chilcott Company, Llc	Antimicrobial quinolones, their compositions and uses
US6613879B1 (en) *	1999-05-14	2003-09-02	Boehringer Ingelheim Pharma Kg	FAP-activated anti-tumour compounds
DE10005275A1 (de) *	2000-02-07	2001-08-09	Bayer Ag	Neuartige Glycokonjugate
US7220824B1 (en) *	2000-08-28	2007-05-22	Bayer Aktiengesellschaft	Integrin-mediated drug targeting
EP1219634A1 (en) *	2000-12-27	2002-07-03	Bayer Aktiengesellschaft	Cytostatic-glycoconjugates having specifically cleavable peptidic linking units
EP1238678A1 (en) *	2001-03-08	2002-09-11	Bayer Aktiengesellschaft	Enzyme-activated cytostatic conjugates with integrin ligands
US20050037423A1 (en) *	2001-11-09	2005-02-17	Bayer Healthcare Ag	Isotopycally coded affinity marker 2
US7199149B2 (en) *	2003-10-01	2007-04-03	Bristol Myers Squibb Company	Monocyclic and bicyclic lactams as factor Xa inhibitors
EP1718677B1 (en)	2003-12-19	2012-04-18	Genentech, Inc.	Monovalent antibody fragments useful as therapeutics
EP1999125A2 (en)	2006-03-28	2008-12-10	The Procter and Gamble Company	A coupling process for preparing quinolone intermediates
EP1999106B1 (en)	2006-03-28	2012-06-27	TaiGen Biotechnology Co., Ltd.	A hydride reduction process for preparing quinolone intermediates
AU2007230630B2 (en)	2006-03-28	2012-12-20	Taigen Biotechnology Co., Ltd	Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
HK1245280A1 (zh)	2015-01-06	2018-08-24	Immunovaccine Technologies Inc.	脂质a模拟物、其制备方法和用途
SMT202400223T1 (it)	2015-11-25	2024-07-09	Ligachem Biosciences Inc	Coniugati comprendenti gruppi autoimmolativi e metodi correlati ad essi
KR102847350B1 (ko)	2015-11-25	2025-08-19	주식회사 리가켐바이오사이언스	분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법
JP7664680B2 (ja)	2017-03-29	2025-04-18	リガケムバイオサイエンシズ，インク．	ピロロベンゾジアゼピン二量体前駆体及びそのリガンド－リンカーコンジュゲート化合物
SG11202010443WA (en)	2018-05-09	2020-11-27	Legochem Biosciences Inc	Compositions and methods related to anti-cd19 antibody drug conjugates
KR20210028544A (ko)	2019-09-04	2021-03-12	주식회사 레고켐 바이오사이언스	인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도
JP2024537169A (ja) *	2021-10-06	2024-10-10	サムヤンコーポレイション	飽和フロジオキシン誘導体化合物及びその二次電池用添加剤としての使用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5977356A (ja) *	1982-06-30	1984-05-02	Fuji Photo Film Co Ltd	螢光アツセイ用多層分析要素およびそれを用いる螢光アツセイ法
DE3611194A1 (de)	1986-04-04	1987-10-08	Bayer Ag	Cancerostatisches mittel
DE3889956T2 (de) *	1987-03-26	1994-12-22	Neorx Corp	Metall-Radionuklid-markierte Proteine und Glykoproteine zur Diagnose und Therapie.
US4975278A (en)	1988-02-26	1990-12-04	Bristol-Myers Company	Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
US4980343A (en) *	1988-10-27	1990-12-25	Bayer Aktiengesellschaft	Aminooxodihydroisoindoloquinazoline carcinostatic agents
DE3837825A1 (de)	1988-11-08	1990-05-10	Hoechst Ag	Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
NZ236393A (en) *	1989-12-13	1992-05-26	Lilly Co Eli	N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
US5160727A (en) *	1990-02-13	1992-11-03	Warner-Lambert Company	Tumor cell sensitization method using quinazolinedione derivatives
US6075121A (en)	1990-05-15	2000-06-13	Chiron Corporation	Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
US5420297A (en)	1990-10-24	1995-05-30	Fujisawa Pharmaceutical Co., Ltd.	Peptides having substance P antagonistic activity
US5399363A (en) *	1991-01-25	1995-03-21	Eastman Kodak Company	Surface modified anticancer nanoparticles
DE4106101A1 (de) *	1991-02-27	1992-09-03	Bayer Ag	Fucose-markierte cytostatika
US5595732A (en) *	1991-03-25	1997-01-21	Hoffmann-La Roche Inc.	Polyethylene-protein conjugates
FR2676058B1 (fr)	1991-04-30	1994-02-25	Hoechst Lab	Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
DE4120646A1 (de)	1991-06-22	1992-12-24	Bayer Ag	7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
ES2137937T3 (es)	1991-11-29	2000-01-01	Hoechst Ag	Peptidos con efecto del tipo de insulina.
SE9103612D0 (sv)	1991-12-04	1991-12-04	Astra Ab	New peptide derivatives
FI933472A7 (fi)	1992-08-07	1994-02-08	Sankyo Co	Peptider med foermaoga att inhibera effekten av HIV-proteas, deras framstaellning och terapeutiska anvaendning
US5872207A (en)	1992-09-04	1999-02-16	Sanofi Pharmaceuticals, Inc.	N-terminal-marked peptides immobilized on glass beads and method of preparation and method of use thereof
IL106998A0 (en)	1992-09-17	1993-12-28	Univ Florida	Brain-enhanced delivery of neuroactive peptides by sequential metabolism
DE4236237A1 (de) *	1992-10-27	1994-04-28	Behringwerke Ag	Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
US5576298A (en)	1992-11-30	1996-11-19	Research And Development Institute, Inc. At Montana State University	Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
SE9300012D0 (sv)	1993-01-05	1993-01-05	Astra Ab	New peptides
US5750648A (en)	1993-08-20	1998-05-12	G.D. Searle & Co.	Retroviral protease inhibitors and combinations thereof
EP0647450A1 (en)	1993-09-09	1995-04-12	BEHRINGWERKE Aktiengesellschaft	Improved prodrugs for enzyme mediated activation
GB9320781D0 (en)	1993-10-08	1993-12-01	Erba Carlo Spa	Polymer-bound camptothecin derivatives
WO1995010296A1 (en) *	1993-10-12	1995-04-20	Glycomed Incorporated	A library of glyco-peptides useful for identification of cell adhesion inhibitors
US5610145A (en)	1994-04-15	1997-03-11	Warner-Lambert Company	Tachykinin antagonists
US5780589A (en)	1994-11-30	1998-07-14	The United States Of America As Represented By The Department Of Health And Human Services	Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
FR2729668A1 (fr)	1995-01-23	1996-07-26	Adir	Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5677286A (en) *	1995-04-27	1997-10-14	The University Of Michigan	Glycosylated analogs of camptothecin
US6143931A (en)	1997-04-16	2000-11-07	Arqule, Inc.	Synthesis and use of α-ketoamide derivatives and arrays

1995
- 1995-04-04 DE DE19512484A patent/DE19512484A1/de not_active Withdrawn
1996
- 1996-03-22 CN CN96194180A patent/CN1185786A/zh active Pending
- 1996-03-22 EP EP96910926A patent/EP0819135B1/de not_active Expired - Lifetime
- 1996-03-22 DK DK96910926T patent/DK0819135T3/da active
- 1996-03-22 CZ CZ19973143A patent/CZ291098B6/cs not_active IP Right Cessation
- 1996-03-22 HU HU9800513A patent/HUP9800513A3/hu unknown
- 1996-03-22 US US08/930,546 patent/US6271342B1/en not_active Expired - Fee Related
- 1996-03-22 RU RU97118421/04A patent/RU2170234C2/ru not_active IP Right Cessation
- 1996-03-22 PL PL96322681A patent/PL183574B1/pl unknown
- 1996-03-22 AU AU53976/96A patent/AU713466B2/en not_active Ceased
- 1996-03-22 BR BR9604825A patent/BR9604825A/pt not_active IP Right Cessation
- 1996-03-22 WO PCT/EP1996/001279 patent/WO1996031532A1/de not_active Ceased
- 1996-03-22 MX MX9707613A patent/MX9707613A/es unknown
- 1996-03-22 DE DE59603678T patent/DE59603678D1/de not_active Expired - Fee Related
- 1996-03-22 CA CA002217164A patent/CA2217164A1/en not_active Abandoned
- 1996-03-22 ES ES96910926T patent/ES2140078T3/es not_active Expired - Lifetime
- 1996-03-22 UA UA97115364A patent/UA61054C2/uk unknown
- 1996-03-22 AT AT96910926T patent/ATE186738T1/de not_active IP Right Cessation
- 1996-03-22 EE EE9700258A patent/EE03619B1/xx not_active IP Right Cessation
- 1996-03-22 SK SK1345-97A patent/SK281785B6/sk unknown
- 1996-03-22 NZ NZ305855A patent/NZ305855A/xx unknown
- 1996-03-22 JP JP8529934A patent/JPH11502860A/ja not_active Ceased
- 1996-03-22 KR KR1019970706996A patent/KR19980703591A/ko not_active Abandoned
- 1996-10-01 TW TW085111956A patent/TW384290B/zh not_active IP Right Cessation
1997
- 1997-09-16 BG BG101892A patent/BG63048B1/bg unknown
- 1997-09-18 IS IS4562A patent/IS1822B/is unknown
- 1997-10-02 NO NO974564A patent/NO974564L/no not_active Application Discontinuation
2000
- 2000-02-09 GR GR20000400304T patent/GR3032605T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EE9700258A (et)	1998-04-15
EP0819135A1 (de)	1998-01-21
BR9604825A (pt)	1999-01-05
SK281785B6 (sk)	2001-07-10
IS4562A (is)	1997-09-18
UA61054C2 (en)	2003-11-17
PL322681A1 (en)	1998-02-16
BG63048B1 (bg)	2001-02-28
HUP9800513A2 (hu)	1998-06-29
AU5397696A (en)	1996-10-23
GR3032605T3 (en)	2000-05-31
RU2170234C2 (ru)	2001-07-10
DE59603678D1 (de)	1999-12-23
AU713466B2 (en)	1999-12-02
SK134597A3 (en)	1998-05-06
HUP9800513A3 (en)	1998-09-28
PL183574B1 (pl)	2002-06-28
MX9707613A (es)	1997-12-31
CZ314397A3 (cs)	1998-01-14
ES2140078T3 (es)	2000-02-16
US6271342B1 (en)	2001-08-07
CA2217164A1 (en)	1996-10-10
KR19980703591A (ko)	1998-11-05
NO974564D0 (no)	1997-10-02
NZ305855A (en)	1999-11-29
ATE186738T1 (de)	1999-12-15
DE19512484A1 (de)	1996-10-17
EE03619B1 (et)	2002-02-15
BG101892A (en)	1998-05-29
CN1185786A (zh)	1998-06-24
NO974564L (no)	1997-11-25
CZ291098B6 (cs)	2002-12-11
DK0819135T3 (da)	2000-05-08
WO1996031532A1 (de)	1996-10-10
JPH11502860A (ja)	1999-03-09
EP0819135B1 (de)	1999-11-17
TW384290B (en)	2000-03-11

Publication	Publication Date	Title
IS4562A (is)	1997-09-18	Glýkósamstæður, lyf sem innihalda þær, og notkun glýkósamstæðnanna við framleiðslu lyfja
NO976031L (no)	1998-02-13	Lavviskös, höykonsentrert friksjonsreduserende middel og fremstilling derav
AP1703A (en)	2007-02-26	Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
DE69738961D1 (de)	2008-10-16	Screening von verbindungen zu ihrer fähigkeit um die herstellung von beta-amyloid peptiden zu veränderen
ES2130420T3 (es)	1999-07-01	Preparado transdermico de sustancia activa.
FI953442A0 (fi)	1995-07-14	Gonadotropiinia sisältäviä pakastekuivattuja pallosia
DK0703786T3 (da)	2002-05-27	Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
TR200100054T2 (tr)	2001-06-21	Paroksetin metansülfonat
DE3574019D1 (en)	1989-12-07	Avermectin and milbemycin 13-keto, 13-imino and 13-amino derivatives
SE9802729D0 (sv)	1998-08-13	Novel Compounds
BR9812182A (pt)	2002-01-15	Cloreto de n,n-bis(fenilcarbamoilmetil) dimetilamÈnio e seus derivados no tratamento da dor
MX9805939A (es)	1998-11-30	Formas solidas de administracion, de liberacion instantanea y procesos para su produccion.
CA2136841A1 (en)	1994-01-20	Novel Piperidyl Amides, Sulfonamides and Sulfoxamides as Inhibitors of Cholesterol Biosynthesis
BR9802803A (pt)	2000-03-21	ação e composições farmacêuticas contendo os mesmos.
ZA966616B (en)	1997-02-18	Benzenesulphonamide derivatives, their preparation and their application in theraphy.
AU4963985A (en)	1986-04-08	Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
NO963113L (no)	1996-09-17	Farmasöytiske preparater omfattende hirudin
EP0609292A4 (en)	1995-10-25	Soluble variants of type i membrane proteins, and methods of using them.
WO1998024482A3 (de)	1999-04-01	Verwendung von endothelin-konjugaten in der therapie, neue endothelin-konjugate, diese enthaltende mittel, sowie verfahren zu deren herstellung
NO885406L (no)	1989-06-08	Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.
RU95105341A (ru)	1996-12-10	Водка "презент"
YU53596A (sh)	1998-09-18	Citostatici modifikovani sa ugljenim hidratima
FI940822A0 (fi)	1994-02-21	Foerfarande foer mikrobiologisk rening av material, som innehaoller skadliga aemnen
WO2000033861A3 (en)	2000-08-10	Pharmaceutical compositions containing protein-disulfide isomerases
FR2544323B1 (fr)	1987-10-30	Nouveaux polycondensats et leurs utilisations notamment en cosmetique